Back to News
Market Impact: 0.3

Guru Fundamental Report for HUM

HUMNDAQ
Company FundamentalsAnalyst InsightsM&A & RestructuringHealthcare & BiotechShort Interest & Activism
Guru Fundamental Report for HUM

Validea's guru report indicates Humana Inc. (HUM) is the highest-rated stock among its strategies by Tobias Carlisle's Acquirer's Multiple Investor model, which targets inexpensive potential takeover candidates. However, HUM's 63% rating falls below the 80% threshold for 'some interest' and it specifically failed the model's core Acquirer's Multiple valuation criterion, suggesting it does not currently strongly align with the deep value, M&A-focused profile sought by this strategy.

Analysis

A Validea report on Humana Inc. (HUM) presents a fundamentally contradictory signal for deep value investors. While HUM is noted as the highest-rated stock among 22 strategies according to Tobias Carlisle's Acquirer's Multiple model, its specific rating of 63% falls well short of the 80% threshold considered indicative of interest. The most critical takeaway is the stock's explicit failure on the model's core "ACQUIRER'S MULTIPLE" criterion, the very metric designed to identify inexpensive takeover targets. Although the company passes on qualitative checks for "SECTOR" and "QUALITY," this failure on the primary valuation test suggests that despite possessing some favorable attributes, HUM is not currently priced as a compelling deep value opportunity or an attractive M&A candidate under this specific, widely followed framework. The mildly negative sentiment score of -0.3 for HUM reinforces this conclusion, highlighting that the underlying data points to a weak, rather than strong, alignment with the strategy.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

mildly negative

Sentiment Score

-0.20

Ticker Sentiment

HUM-0.30
NDAQ0.00

Key Decisions for Investors

  • Investors following a strict Acquirer's Multiple or deep value strategy should interpret this report as a contra-indicator for Humana, as it explicitly fails the core valuation test of the model.
  • Speculators focused on M&A potential should note that this specific model, designed to find takeover targets, does not currently flag Humana as an attractive candidate on a valuation basis.
  • Investors should not be misled by the 'highest-rated' headline; the underlying score of 63% and failure on the key multiple suggest a lack of a compelling value proposition from this specific analytical perspective, despite positive quality attributes.